Analysis of trends in single inhaler triple therapy (SITT) use and clinical characteristics of patients with severe asthma: data from the IRSA registry Article Swipe
Francesco Menzella
,
Matteo Martini
,
Maria Beatrice Bilò
,
Leonardo Antonicelli
,
Lorenzo Cecchi
,
Francesca de Michele
,
A Vaghi
,
A Musarra
,
Claudio Micheletto
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.23822/eurannaci.1764-1489.417
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.23822/eurannaci.1764-1489.417
Background. Triple therapy with inhaled corticosteroids (ICS), long-acting β₂-agonists (LABA), and long-acting muscarinic antagonists (LAMA) is recommended for severe asthma patients with uncontrolled symptoms. Single-inhaler triple therapy (SITT) may offer additional clinical and practical benefits. This study analyzes the clinical profiles of patients receiving LAMA-containing regimens using real-world data from the Italian Registry on Severe Asthma (IRSA). Methods. We conducted a cross-sectional analysis of 2,155 patients with severe asthma enrolled in IRSA between 2018 and May 2025. Patients were stratified based on LAMA use ("LAMA Yes" vs. "LAMA No") and assessed across demographics, lung function, biomarkers, asthma control, healthcare utilization, and comorbidities. Results. Patients on triple therapy were older, had a greater smoking history, and worse lung function (FEV₁ and FVC, p<0.001). They also reported poorer asthma control (mean ACT 16 vs. 17.5, p<0.001), more exacerbations (3.6 vs. 2.8/year, p<0.001), higher systemic corticosteroid use, and more comorbidities, including obesity and bronchiectasis. Interestingly, no significant differences were observed in type 2 inflammation markers (eosinophils, FeNO). The odds of receiving a LAMA prescription increased with age and a higher number of exacerbations. Conclusions. Triple therapy, especially through SITT, identifies a clinically complex asthma phenotype with a high disease burden. Despite growing evidence supporting efficacy and adherence benefits, triple therapy remains relatively underutilized in clinical practice, albeit with a significant increase from 2023 to the present. These findings highlight the need for more careful prescribing and further real-world evidence to optimize SITT positioning before escalation to biologic treatments.
Related Topics
Concepts
No concepts available.
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.23822/eurannaci.1764-1489.417
- https://www.eurannallergyimm.com/wp-content/uploads/2025/10/Menzella_OF.pdf
- OA Status
- bronze
- OpenAlex ID
- https://openalex.org/W4415040327
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4415040327Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.23822/eurannaci.1764-1489.417Digital Object Identifier
- Title
-
Analysis of trends in single inhaler triple therapy (SITT) use and clinical characteristics of patients with severe asthma: data from the IRSA registryWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-10-01Full publication date if available
- Authors
-
Francesco Menzella, Matteo Martini, Maria Beatrice Bilò, Leonardo Antonicelli, Lorenzo Cecchi, Francesca de Michele, A Vaghi, A Musarra, Claudio MichelettoList of authors in order
- Landing page
-
https://doi.org/10.23822/eurannaci.1764-1489.417Publisher landing page
- PDF URL
-
https://www.eurannallergyimm.com/wp-content/uploads/2025/10/Menzella_OF.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://www.eurannallergyimm.com/wp-content/uploads/2025/10/Menzella_OF.pdfDirect OA link when available
- Cited by
-
0Total citation count in OpenAlex
Full payload
| id | https://openalex.org/W4415040327 |
|---|---|
| doi | https://doi.org/10.23822/eurannaci.1764-1489.417 |
| ids.doi | https://doi.org/10.23822/eurannaci.1764-1489.417 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/41070812 |
| ids.openalex | https://openalex.org/W4415040327 |
| fwci | 0.0 |
| type | article |
| title | Analysis of trends in single inhaler triple therapy (SITT) use and clinical characteristics of patients with severe asthma: data from the IRSA registry |
| biblio.issue | online first |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11651 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.8865000009536743 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2740 |
| topics[0].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[0].display_name | Inhalation and Respiratory Drug Delivery |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| language | en |
| locations[0].id | doi:10.23822/eurannaci.1764-1489.417 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2754288800 |
| locations[0].source.issn | 1764-1489 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1764-1489 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | European Annals of Allergy and Clinical Immunology |
| locations[0].source.host_organization | |
| locations[0].source.host_organization_name | |
| locations[0].source.host_organization_lineage | |
| locations[0].license | |
| locations[0].pdf_url | https://www.eurannallergyimm.com/wp-content/uploads/2025/10/Menzella_OF.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | European Annals of Allergy and Clinical Immunology |
| locations[0].landing_page_url | https://doi.org/10.23822/eurannaci.1764-1489.417 |
| locations[1].id | pmid:41070812 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | European annals of allergy and clinical immunology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/41070812 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5070079416 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-3950-5789 |
| authorships[0].author.display_name | Francesco Menzella |
| authorships[0].affiliations[0].raw_affiliation_string | Pulmonology Unit, S. Valentino Hospital, Montebelluna (TV), AULSS2 Marca Trevigiana, Treviso, Italy. |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | F Menzella |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Pulmonology Unit, S. Valentino Hospital, Montebelluna (TV), AULSS2 Marca Trevigiana, Treviso, Italy. |
| authorships[1].author.id | https://openalex.org/A5035317267 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-9873-9695 |
| authorships[1].author.display_name | Matteo Martini |
| authorships[1].countries | IT |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I122534668 |
| authorships[1].affiliations[0].raw_affiliation_string | Allergy Unit, Department of Internal Medicine, University Hospital of Marche, Ancona, Italy. |
| authorships[1].institutions[0].id | https://openalex.org/I122534668 |
| authorships[1].institutions[0].ror | https://ror.org/00x69rs40 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I122534668 |
| authorships[1].institutions[0].country_code | IT |
| authorships[1].institutions[0].display_name | Marche Polytechnic University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | M Martini |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Allergy Unit, Department of Internal Medicine, University Hospital of Marche, Ancona, Italy. |
| authorships[2].author.id | https://openalex.org/A5008442256 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-9324-6039 |
| authorships[2].author.display_name | Maria Beatrice Bilò |
| authorships[2].countries | IT |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I122534668 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy. |
| authorships[2].institutions[0].id | https://openalex.org/I122534668 |
| authorships[2].institutions[0].ror | https://ror.org/00x69rs40 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I122534668 |
| authorships[2].institutions[0].country_code | IT |
| authorships[2].institutions[0].display_name | Marche Polytechnic University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | M B Bilò |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy. |
| authorships[3].author.id | https://openalex.org/A5079696011 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-7669-9116 |
| authorships[3].author.display_name | Leonardo Antonicelli |
| authorships[3].countries | IT |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210107146 |
| authorships[3].affiliations[0].raw_affiliation_string | Allergy and Asthma Outpatient Clinic, Ancona, Italy. |
| authorships[3].institutions[0].id | https://openalex.org/I4210107146 |
| authorships[3].institutions[0].ror | https://ror.org/01j0qa041 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210107146 |
| authorships[3].institutions[0].country_code | IT |
| authorships[3].institutions[0].display_name | Ospedali Riuniti di Ancona |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | L Antonicelli |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Allergy and Asthma Outpatient Clinic, Ancona, Italy. |
| authorships[4].author.id | https://openalex.org/A5030494163 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-0658-2449 |
| authorships[4].author.display_name | Lorenzo Cecchi |
| authorships[4].countries | IT |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210156604 |
| authorships[4].affiliations[0].raw_affiliation_string | Allergology and Clinical Immunology Unit, Sanitary District Toscana Centro, Prato, Italy. |
| authorships[4].institutions[0].id | https://openalex.org/I4210156604 |
| authorships[4].institutions[0].ror | https://ror.org/05a87zb20 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210156604 |
| authorships[4].institutions[0].country_code | IT |
| authorships[4].institutions[0].display_name | Azienda Usl Toscana Centro |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | L Cecchi |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Allergology and Clinical Immunology Unit, Sanitary District Toscana Centro, Prato, Italy. |
| authorships[5].author.id | https://openalex.org/A5037946770 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-9302-9122 |
| authorships[5].author.display_name | Francesca de Michele |
| authorships[5].countries | IT |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210108212 |
| authorships[5].affiliations[0].raw_affiliation_string | Pulmonology and Respiratory Pathophysiology Unit, A. Cardarelli Hospital, Naples, Italy. |
| authorships[5].institutions[0].id | https://openalex.org/I4210108212 |
| authorships[5].institutions[0].ror | https://ror.org/01x9zv505 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210108212, https://openalex.org/I4210153126 |
| authorships[5].institutions[0].country_code | IT |
| authorships[5].institutions[0].display_name | Fatebenefratelli Hospital |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | F de Michele |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Pulmonology and Respiratory Pathophysiology Unit, A. Cardarelli Hospital, Naples, Italy. |
| authorships[6].author.id | https://openalex.org/A5019665867 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | A Vaghi |
| authorships[6].affiliations[0].raw_affiliation_string | Former Head of Pneumology and Chief of Department of Medicine and Rehabilitation, Guido Salvini Hospital-ASST Rhodense, Garbagnate Milanese, Milan, Italy. |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | A Vaghi |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Former Head of Pneumology and Chief of Department of Medicine and Rehabilitation, Guido Salvini Hospital-ASST Rhodense, Garbagnate Milanese, Milan, Italy. |
| authorships[7].author.id | https://openalex.org/A5050928715 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | A Musarra |
| authorships[7].affiliations[0].raw_affiliation_string | Allergy Unit, Casa della Salute di Scilla, Scilla, Reggio Calabria, Italy. |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | A Musarra |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Allergy Unit, Casa della Salute di Scilla, Scilla, Reggio Calabria, Italy. |
| authorships[8].author.id | https://openalex.org/A5043459938 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-1138-3882 |
| authorships[8].author.display_name | Claudio Micheletto |
| authorships[8].countries | IT |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I119439378 |
| authorships[8].affiliations[0].raw_affiliation_string | Pulmonary Unit, Integrated University Hospital of Verona, Verona, Italy. |
| authorships[8].institutions[0].id | https://openalex.org/I119439378 |
| authorships[8].institutions[0].ror | https://ror.org/039bp8j42 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I119439378 |
| authorships[8].institutions[0].country_code | IT |
| authorships[8].institutions[0].display_name | University of Verona |
| authorships[8].author_position | last |
| authorships[8].raw_author_name | C Micheletto |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Pulmonary Unit, Integrated University Hospital of Verona, Verona, Italy. |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.eurannallergyimm.com/wp-content/uploads/2025/10/Menzella_OF.pdf |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-11T00:00:00 |
| display_name | Analysis of trends in single inhaler triple therapy (SITT) use and clinical characteristics of patients with severe asthma: data from the IRSA registry |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11651 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.8865000009536743 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2740 |
| primary_topic.subfield.display_name | Pulmonary and Respiratory Medicine |
| primary_topic.display_name | Inhalation and Respiratory Drug Delivery |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.23822/eurannaci.1764-1489.417 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2754288800 |
| best_oa_location.source.issn | 1764-1489 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1764-1489 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | European Annals of Allergy and Clinical Immunology |
| best_oa_location.source.host_organization | |
| best_oa_location.source.host_organization_name | |
| best_oa_location.source.host_organization_lineage | |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://www.eurannallergyimm.com/wp-content/uploads/2025/10/Menzella_OF.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | European Annals of Allergy and Clinical Immunology |
| best_oa_location.landing_page_url | https://doi.org/10.23822/eurannaci.1764-1489.417 |
| primary_location.id | doi:10.23822/eurannaci.1764-1489.417 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2754288800 |
| primary_location.source.issn | 1764-1489 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1764-1489 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | European Annals of Allergy and Clinical Immunology |
| primary_location.source.host_organization | |
| primary_location.source.host_organization_name | |
| primary_location.source.host_organization_lineage | |
| primary_location.license | |
| primary_location.pdf_url | https://www.eurannallergyimm.com/wp-content/uploads/2025/10/Menzella_OF.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | European Annals of Allergy and Clinical Immunology |
| primary_location.landing_page_url | https://doi.org/10.23822/eurannaci.1764-1489.417 |
| publication_date | 2025-10-01 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index.2 | 159 |
| abstract_inverted_index.a | 60, 110, 168, 175, 187, 193, 215 |
| abstract_inverted_index.16 | 130 |
| abstract_inverted_index.We | 58 |
| abstract_inverted_index.in | 70, 157, 210 |
| abstract_inverted_index.is | 15 |
| abstract_inverted_index.no | 152 |
| abstract_inverted_index.of | 41, 63, 166, 178 |
| abstract_inverted_index.on | 53, 81, 104 |
| abstract_inverted_index.to | 220, 236, 242 |
| abstract_inverted_index.ACT | 129 |
| abstract_inverted_index.May | 75 |
| abstract_inverted_index.The | 164 |
| abstract_inverted_index.age | 173 |
| abstract_inverted_index.and | 10, 32, 74, 89, 100, 114, 119, 144, 149, 174, 202, 232 |
| abstract_inverted_index.for | 17, 228 |
| abstract_inverted_index.had | 109 |
| abstract_inverted_index.may | 28 |
| abstract_inverted_index.the | 38, 50, 221, 226 |
| abstract_inverted_index.use | 83 |
| abstract_inverted_index.vs. | 86, 131, 137 |
| abstract_inverted_index.(3.6 | 136 |
| abstract_inverted_index.2018 | 73 |
| abstract_inverted_index.2023 | 219 |
| abstract_inverted_index.FVC, | 120 |
| abstract_inverted_index.IRSA | 71 |
| abstract_inverted_index.LAMA | 82, 169 |
| abstract_inverted_index.No") | 88 |
| abstract_inverted_index.SITT | 238 |
| abstract_inverted_index.They | 122 |
| abstract_inverted_index.This | 35 |
| abstract_inverted_index.Yes" | 85 |
| abstract_inverted_index.also | 123 |
| abstract_inverted_index.data | 48 |
| abstract_inverted_index.from | 49, 218 |
| abstract_inverted_index.high | 194 |
| abstract_inverted_index.lung | 93, 116 |
| abstract_inverted_index.more | 134, 145, 229 |
| abstract_inverted_index.need | 227 |
| abstract_inverted_index.odds | 165 |
| abstract_inverted_index.type | 158 |
| abstract_inverted_index.use, | 143 |
| abstract_inverted_index.were | 78, 107, 155 |
| abstract_inverted_index.with | 3, 21, 66, 172, 192, 214 |
| abstract_inverted_index."LAMA | 87 |
| abstract_inverted_index.(mean | 128 |
| abstract_inverted_index.17.5, | 132 |
| abstract_inverted_index.2,155 | 64 |
| abstract_inverted_index.2025. | 76 |
| abstract_inverted_index.SITT, | 185 |
| abstract_inverted_index.These | 223 |
| abstract_inverted_index.based | 80 |
| abstract_inverted_index.offer | 29 |
| abstract_inverted_index.study | 36 |
| abstract_inverted_index.using | 46 |
| abstract_inverted_index.worse | 115 |
| abstract_inverted_index.("LAMA | 84 |
| abstract_inverted_index.(ICS), | 6 |
| abstract_inverted_index.(LAMA) | 14 |
| abstract_inverted_index.(SITT) | 27 |
| abstract_inverted_index.Asthma | 55 |
| abstract_inverted_index.FeNO). | 163 |
| abstract_inverted_index.Severe | 54 |
| abstract_inverted_index.Triple | 1, 181 |
| abstract_inverted_index.across | 91 |
| abstract_inverted_index.albeit | 213 |
| abstract_inverted_index.asthma | 19, 68, 96, 126, 190 |
| abstract_inverted_index.before | 240 |
| abstract_inverted_index.higher | 140, 176 |
| abstract_inverted_index.number | 177 |
| abstract_inverted_index.older, | 108 |
| abstract_inverted_index.poorer | 125 |
| abstract_inverted_index.severe | 18, 67 |
| abstract_inverted_index.triple | 25, 105, 205 |
| abstract_inverted_index.(FEV₁ | 118 |
| abstract_inverted_index.(IRSA). | 56 |
| abstract_inverted_index.(LABA), | 9 |
| abstract_inverted_index.Despite | 197 |
| abstract_inverted_index.Italian | 51 |
| abstract_inverted_index.between | 72 |
| abstract_inverted_index.burden. | 196 |
| abstract_inverted_index.careful | 230 |
| abstract_inverted_index.complex | 189 |
| abstract_inverted_index.control | 127 |
| abstract_inverted_index.disease | 195 |
| abstract_inverted_index.further | 233 |
| abstract_inverted_index.greater | 111 |
| abstract_inverted_index.growing | 198 |
| abstract_inverted_index.inhaled | 4 |
| abstract_inverted_index.markers | 161 |
| abstract_inverted_index.obesity | 148 |
| abstract_inverted_index.remains | 207 |
| abstract_inverted_index.smoking | 112 |
| abstract_inverted_index.therapy | 2, 26, 106, 206 |
| abstract_inverted_index.through | 184 |
| abstract_inverted_index.Methods. | 57 |
| abstract_inverted_index.Patients | 77, 103 |
| abstract_inverted_index.Registry | 52 |
| abstract_inverted_index.Results. | 102 |
| abstract_inverted_index.analysis | 62 |
| abstract_inverted_index.analyzes | 37 |
| abstract_inverted_index.assessed | 90 |
| abstract_inverted_index.biologic | 243 |
| abstract_inverted_index.clinical | 31, 39, 211 |
| abstract_inverted_index.control, | 97 |
| abstract_inverted_index.efficacy | 201 |
| abstract_inverted_index.enrolled | 69 |
| abstract_inverted_index.evidence | 199, 235 |
| abstract_inverted_index.findings | 224 |
| abstract_inverted_index.function | 117 |
| abstract_inverted_index.history, | 113 |
| abstract_inverted_index.increase | 217 |
| abstract_inverted_index.observed | 156 |
| abstract_inverted_index.optimize | 237 |
| abstract_inverted_index.patients | 20, 42, 65 |
| abstract_inverted_index.present. | 222 |
| abstract_inverted_index.profiles | 40 |
| abstract_inverted_index.regimens | 45 |
| abstract_inverted_index.reported | 124 |
| abstract_inverted_index.systemic | 141 |
| abstract_inverted_index.therapy, | 182 |
| abstract_inverted_index.2.8/year, | 138 |
| abstract_inverted_index.adherence | 203 |
| abstract_inverted_index.benefits, | 204 |
| abstract_inverted_index.benefits. | 34 |
| abstract_inverted_index.conducted | 59 |
| abstract_inverted_index.function, | 94 |
| abstract_inverted_index.highlight | 225 |
| abstract_inverted_index.including | 147 |
| abstract_inverted_index.increased | 171 |
| abstract_inverted_index.p<0.001), | 133, 139 |
| abstract_inverted_index.p<0.001). | 121 |
| abstract_inverted_index.phenotype | 191 |
| abstract_inverted_index.practical | 33 |
| abstract_inverted_index.practice, | 212 |
| abstract_inverted_index.receiving | 43, 167 |
| abstract_inverted_index.symptoms. | 23 |
| abstract_inverted_index.additional | 30 |
| abstract_inverted_index.clinically | 188 |
| abstract_inverted_index.escalation | 241 |
| abstract_inverted_index.especially | 183 |
| abstract_inverted_index.healthcare | 98 |
| abstract_inverted_index.identifies | 186 |
| abstract_inverted_index.muscarinic | 12 |
| abstract_inverted_index.real-world | 47, 234 |
| abstract_inverted_index.relatively | 208 |
| abstract_inverted_index.stratified | 79 |
| abstract_inverted_index.supporting | 200 |
| abstract_inverted_index.Background. | 0 |
| abstract_inverted_index.antagonists | 13 |
| abstract_inverted_index.biomarkers, | 95 |
| abstract_inverted_index.differences | 154 |
| abstract_inverted_index.long-acting | 7, 11 |
| abstract_inverted_index.positioning | 239 |
| abstract_inverted_index.prescribing | 231 |
| abstract_inverted_index.recommended | 16 |
| abstract_inverted_index.significant | 153, 216 |
| abstract_inverted_index.treatments. | 244 |
| abstract_inverted_index.Conclusions. | 180 |
| abstract_inverted_index.inflammation | 160 |
| abstract_inverted_index.prescription | 170 |
| abstract_inverted_index.uncontrolled | 22 |
| abstract_inverted_index.utilization, | 99 |
| abstract_inverted_index.(eosinophils, | 162 |
| abstract_inverted_index.demographics, | 92 |
| abstract_inverted_index.exacerbations | 135 |
| abstract_inverted_index.underutilized | 209 |
| abstract_inverted_index.Interestingly, | 151 |
| abstract_inverted_index.Single-inhaler | 24 |
| abstract_inverted_index.comorbidities, | 146 |
| abstract_inverted_index.comorbidities. | 101 |
| abstract_inverted_index.corticosteroid | 142 |
| abstract_inverted_index.exacerbations. | 179 |
| abstract_inverted_index.β₂-agonists | 8 |
| abstract_inverted_index.LAMA-containing | 44 |
| abstract_inverted_index.bronchiectasis. | 150 |
| abstract_inverted_index.corticosteroids | 5 |
| abstract_inverted_index.cross-sectional | 61 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 9 |
| citation_normalized_percentile.value | 0.65953253 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |